Acute Renal Failure

Chapter

Abstract

Acute renal failure (ARF) is a common problem in the ICU. Even modest degrees of ARF not resulting in dialysis treatment increase the risk of death approximately fivefold.1 The mortality of patients who require dialysis has remained in excess of 50% despite improvements in renal replacement therapy and aggressive supportive care. It is therefore essential that all efforts be made to avoid this complication, i.e., aggressive (early) fluid resuscitation and avoidance of potentially nephrotoxic drugs (especially aminoglycosides and contrast media). The therapeutic intervention of choice in patients with oliguria is fluid resuscitation and not furosemide/Lasix™ (see Chapter 8).

Keywords

Dopamine Cyclosporine Myeloma Vancomycin Tacrolimus 

References

  1. 1.
    Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA. 1996;275:1489–1494.PubMedCrossRefGoogle Scholar
  2. 2.
    Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Low dose dopamine in patients with early renal dysfunction: a placebo-controlled trial. Lancet. 2000;356:2139–2143.Google Scholar
  3. 3.
    Brown CB, Ogg CS, Cameron JS. High dose furosemide in acute renal failure: a controlled trial. Clin Nephrol. 1981;15:90–96.PubMedGoogle Scholar
  4. 4.
    Lucas CE, Zito JG, Carter KM, et al. Questionable value of furosemide in preventing renal failure. Surgery. 1977;82:341–320.Google Scholar
  5. 5.
    Kleinknecht D, Ganeval D, Gonzalez-Duque LA, et al. Furosemide in acute oliguric renal failure. A controlled trial. Nephron. 1976;17:51–58.PubMedCrossRefGoogle Scholar
  6. 6.
    Mehta RL, Pascual MT, Soroko S, et al. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002;288:2547–2553.PubMedCrossRefGoogle Scholar
  7. 7.
    Ho KM, Sheridan DJ. Meta-analysis of furosemide to prevent or treat acute renal failure. BMJ. 2006;333:420.PubMedCrossRefGoogle Scholar
  8. 8.
    Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol. 1999;9:1602–1613.PubMedCrossRefGoogle Scholar
  9. 9.
    Thomsen HS, Morcos SK. Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines. Eur Radiol. 2006;16:1835–1840.PubMedCrossRefGoogle Scholar
  10. 10.
    Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology. 1993;188:171–178.PubMedGoogle Scholar
  11. 11.
    Kelly AM, Dwamena B, Cronin P, et al. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 2008;148:284–294.PubMedGoogle Scholar
  12. 12.
    Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med. 2006;354:2773–2782.PubMedCrossRefGoogle Scholar
  13. 13.
    Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343:180–184.PubMedCrossRefGoogle Scholar
  14. 14.
    Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:1416–1420.PubMedCrossRefGoogle Scholar
  15. 15.
    Weisbord SD, Palevsky PM. Acute renal failure in the intensive care unit. Semin Respir Crit Care Med. 2006;27:262–273.PubMedCrossRefGoogle Scholar
  16. 16.
    Pannu N, Klarenbach S, Wiebe N, et al. Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA. 2008;299:793–805.PubMedCrossRefGoogle Scholar
  17. 17.
    Mehta RL, McDonald B, Gabbai FB, et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int. 2001;60:1154–1163.PubMedCrossRefGoogle Scholar
  18. 18.
    Augustine JJ, Sandy D, Seifert TH, et al. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis. 2004;44:1000–1007.PubMedCrossRefGoogle Scholar
  19. 19.
    Tonelli M, Manns B, Feller-Kopman D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis. 2002;40:875–885.PubMedCrossRefGoogle Scholar
  20. 20.
    Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000;356:26–30.PubMedCrossRefGoogle Scholar
  21. 21.
    Palevsky PM, Zhang JH, O'Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359:7–20.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Division of Pulmonary and Critical Care MedicineEastern Virginia Medical SchoolNorfolkUSA

Personalised recommendations